Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Drug News

Added 19 hours ago Drug news

FDA approves Otelza for the treatment of oral ulcers associated with Behçet’s disease.

Celgene Corporation announced that the FDA has approved Otezla (apremilast) 30 mg twice daily (BID) for the treatment of adult...

Added 19 hours ago Drug news

Interim data from an ongoing investigator-sponsored clinical trial led by Baylor College of Medicine evaluating MultiTAA T cell therapy in patients with pancreatic adenocarcinoma.- Marker Therapeutics

Marker Therapeutics, Inc. announced interim data from an ongoing investigator-sponsored clinical trial led by Baylor College of Medicine , evaluating...

Added 1 day ago Drug news

FDA 510(k) clearance for LifeSPARC system advanced circulatory support (ACS) pump.- LivaNova PLC

LivaNova PLC announced it has received 510(k) clearance from the FDA for its new Advanced Circulatory Support (ACS) pump and...

Added 1 day ago Drug news

CE Mark for ProFound AI for 2D mammography software system to analyze 2D mammography scans . ICAD

ICAD, has secured European CE Mark approval for its ProFound AI for 2D Mammography software system. The product relies on...

Industry news

Added 2 days ago Industry news

AbbVi acquires Mavupharma and with it MAVU 104, a first-in-class, orally active, small molecule inhibitor of ENPP1 an enzyme involved in the regulation of the STING pathway

AbbVie announced that it has acquired Seattle-based Mavupharma, a privately held biopharmaceutical company focused on novel approaches to target the...

Added 9 days ago Industry news

Altimmune Inc. acquires Spitfire Pharma and with it NASH product candidate SP 1373

Altimmune, Inc.a clinical-stage biopharmaceutical company, announced that it has entered into an agreement to acquire Spitfire Pharma, Inc. including its...

Added 25 days ago Industry news

AbbVie to acquire Allergan for $63 billion

AbbVie Inc. and Allergan plc announced that the companies have entered into a definitive transaction agreement under which AbbVie will...